Solid biosciences announces appointment of michael inbar, cpa, mba, as senior vice president, finance

Cambridge, mass., aug. 19, 2021 (globe newswire) -- solid biosciences inc. (nasdaq: sldb), a life sciences company focused on advancing meaningful therapies for duchenne muscular dystrophy (duchenne), today announced that michael inbar, cpa, mba, has joined the company as senior vice president, finance, effective august 16, 2021.
SLDB Ratings Summary
SLDB Quant Ranking